The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCs

Cytotherapy

Volumn 11, Issue 4, 2009, Pages 403-413

  Capelli, Chiara ^a   Salvadè, Agnese ^b   Pedrini, Olga ^a   Barbui, Valentina ^a   Gotti, Elisa ^a   Borleri, Gianmaria ^a   Cabiati, Benedetta ^b   Belotti, Daniela ^b   Perseghin, Paolo ^b,c   Bellavita, Piero ^a   Biondi, Andrea ^b   Biagi, Ettore ^b   Rambaldi, Alessandro ^a   Golay, Josee ^a   Introna, Martino ^a  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

Graft versus host disease; Human platelet lysate; Mesenchymal stromal cells

Indexed keywords

ENDOGLIN; THY 1 ANTIGEN;

ADULT; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; CELL ISOLATION; CELL LYSATE; CELL MATURATION; CELL VIABILITY; CHILD; COLONY FORMING UNIT F; CRYOPRESERVATION; DISCARDED BONE MARROW COLLECTION BAGS AND FILLTER WASHOUT; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; ISOLATION PROCEDURE; KARYOTYPING; MALE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; QUALITY CONTROL; VALIDATION PROCESS;

EID: 68049116669     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240902960437     Document Type: Article

References (20)

1. Ning H, Yang F, Jiang M, Hu L, Feng K, Zhang J et al. The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: Outcome of a pilot clinical study. Leukemia 2008;22: 593-9.
2. Vianello F, Dazzi F. Mesenchymal stem cells for graft-versushost disease: A double edged sword? Leukemia 2008;22:463-5.
3. Muller I, Kordowich S, Holzwarth C, Isensee G, Lang P, Neunhoeffer F et al. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation. Blood Cells Mol Dis 2008;40:25-32.
4. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 2008;371:1579-86.
5. Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006;81:1390-7.
6. Ringden O, Uzunel M, Sundberg B, Lonnies L, Nava S, Gustafsson J et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 2007;21:2271-6.
7. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-41.
8. Capelli C, Domenghini M, Borleri G, Bellavita P, Poma R, Carobbio A et al. Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant 2007;40:785-91.
9. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;56:289-301.
10. Caspersson T, Zech L, Johansson C, Modest EJ. Identification of human chromosomes by DNA-binding fluorescent agents. Chromosoma 1970;30:215-27.
11. Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 2007;47:1436-46.
12. Salvade A, Belotti D, Donzelli E, D'Amico G, Gaipa G, Renoldi G et al. GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease. Cytotherapy 2007;9:427-38.
13. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X et al. Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 2005;205:228-36.
14. Lange C, Cakiroglu F, Spiess AN, Cappallo-Obermann H, Dierlamm J, Zander AR. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 2007;213:18-26.
15. Carrancio S, Lopez-Holgado N, Sanchez-Guijo FM, Villaron E, Barbado V, Tabera S et al. Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol 2008;36:1014-21.
16. Muller I, Kordowich S, Holzwarth C, Spano C, Isensee G, Staiber A et al. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 2006;8:437-44.
17. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 2006;24:462-71.
18. Mageed AS, Pietryga DW, DeHeer DH, West RA. Isolation of large numbers of mesenchymal stem cells from the washings of bone marrow collection bags: Characterization of fresh mesenchymal stem cells. Transplantation 2007;83:1019-26.
19. Sundin M, Remberger M, Lonnies H, Sundberg B, Ringden O, Le Blanc K. No increased trapping of multipotent mesenchymal stromal cells in bone marrow filters compared with other bone marrow cells. Cytotherapy 2008;10:238-42.
20. Dvorakova J, Hruba A, Velebny V, Kubala L. Isolation and characterization of mesenchymal stem cell population entrapped in bone marrow collection sets. Cell Biol Int 2008;32:1116-25.